http://www.digitaljournal.com/article/351184

Olympia Pharmacy recalls products from U.S. market

Posted May 30, 2013 by Tim Sandle
Another U.S. compounding pharmacy has recalled its medicines from the U.S. market due to concerns about the quality and sterility of the medicines.
Coming just a few days after the Digital Journal reported that the Main Street Family Pharmacy, LLC (Main Street) of Newbern, Tenn. was recalling its sterile medicines due to concerns with the risk of infection comes the news that Olympia Pharmacy has announced a similar move.
According to the U.S. Food and Drug Administration (FDA) Medwatch service, the company Lowlite Investments who run the Olympia Pharmacy has notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy . The recall is being initiated due to concerns associated with quality control procedures that have impacted upon the sterility assurance of the products.
The FDA warns that in the event a sterile product is compromised patients are at risk for serious and possible life threatening infections.
The recall, as noted in an Olympia Pharmacy press release, includes all sterile products that Olympia Pharmacy supplied to patients and offices of licensed medical professionals with a use by date of 09/25/2013 or earlier. A list of the affected medicines can be found on the FDA site.
The Digital Journal has run a series of news stories on the state of U.S. pharmacies and the recent round of inspections undertaken by the U.S. Food and Drug Administration (FDA).